Explore All Access
Check if your research matches the topics covered in Current Hematologic Malignancy Reports?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Current Hematologic Malignancy Reports : Impact Factor & More
eISSN: 1558-822XpISSN: 1558-8211
Share this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Current Hematologic Malignancy Reports Key Metrics
CiteScore 
6.5
Eigenfactor
0.001 - 0.005
H-Index
40
Impact Factor
< 5
SJR
Q2Oncology
SNIP
1.27
Topics Covered on Current Hematologic Malignancy Reports
B-cell lymphoma
Immunotherapy
Minimal residual disease
Monoclonal antibody
Diffuse large B-cell lymphoma
Toxicity
Chimeric antigen receptor
Hematopoietic stem cell transplantation
Cell therapy
Bispecific antibody
Hematology clinic
Chemoimmunotherapy
Chronic myelomonocytic leukemia
Bortezomib
Social media
T-cell lymphoma
Immune system
Myelofibrosis
Target antigen
Toxicity profile
Current Hematologic Malignancy Reports Journal Specifications
| Overview | |
| Publisher | CURRENT MEDICINE GROUP |
| Language | English |
| Frequency | Quarterly |
| General Details | |
| Language | English |
| Frequency | Quarterly |
| Publication Start Year | 2005 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
One subscription packed with expert publication services and AI tools to get you published
Brought to you by 
Journal Selection Service
Benefit from our experts' recommendations of 3-5 best-suited journals, accompanied by a detailed Journal Selection report explaining the choices. Make informed decisions.
Journal Submission Service
Streamline your submission process with meticulous manuscript formatting to meet journal guidelines, crafting a tailored cover letter for the editor, and hassle-free account creation and submission
Bundle of AI tools for your research needs
Journal Finder, Paperpal, R Discovery, MindTheGraph and more
Planning to publish in Current Hematologic Malignancy Reports ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Current Hematologic Malignancy Reports
Experimental and Computational Approaches to Measure Telomere Length: Recent Advances and Future Directions
- 10 Nov 2023
- Current Hematologic Malignancy Reports
Sporadic and Familial Acute Myeloid Leukemia with CEBPA Mutations
- 1 Jun 2023
- Current Hematologic Malignancy Reports
Approach to the Treatment of Philadelphia Chromosome-Negative B-cell ALL in Older Adults: Is Age Becoming just a Number?
- 6 Mar 2023
- Current Hematologic Malignancy Reports
The Bone Marrow Immune Microenvironment in CML: Treatment Responses, Treatment-Free Remission, and Therapeutic Vulnerabilities
- 13 Feb 2023
- Current Hematologic Malignancy Reports
Progress and Challenges in Survivorship After Acute Myeloid Leukemia in Adults
- 19 Sep 2022
- Current Hematologic Malignancy Reports
Towards a Personalized Definition of Prognosis in Philadelphia-Negative Myeloproliferative Neoplasms
- 1 Sep 2022
- Current Hematologic Malignancy Reports
Experimental and Computational Approaches to Measure Telomere Length: Recent Advances and Future Directions
- 10 Nov 2023
- Current Hematologic Malignancy Reports
Sporadic and Familial Acute Myeloid Leukemia with CEBPA Mutations
- 1 Jun 2023
- Current Hematologic Malignancy Reports
Approach to the Treatment of Philadelphia Chromosome-Negative B-cell ALL in Older Adults: Is Age Becoming just a Number?
- 6 Mar 2023
- Current Hematologic Malignancy Reports
The Bone Marrow Immune Microenvironment in CML: Treatment Responses, Treatment-Free Remission, and Therapeutic Vulnerabilities
- 13 Feb 2023
- Current Hematologic Malignancy Reports
Progress and Challenges in Survivorship After Acute Myeloid Leukemia in Adults
- 19 Sep 2022
- Current Hematologic Malignancy Reports
Towards a Personalized Definition of Prognosis in Philadelphia-Negative Myeloproliferative Neoplasms
- 1 Sep 2022
- Current Hematologic Malignancy Reports
FAQs on Current Hematologic Malignancy Reports
How long has Current Hematologic Malignancy Reports been actively publishing? 
Current Hematologic Malignancy Reports has been in operation since 2005 till date.
What is the publishing frequency of Current Hematologic Malignancy Reports?
Current Hematologic Malignancy Reports published with a Quarterly frequency.
How many articles did Current Hematologic Malignancy Reports publish last year?
In 2023, Current Hematologic Malignancy Reports publsihed 4 articles.
What is the eISSN & pISSN for Current Hematologic Malignancy Reports?
For Current Hematologic Malignancy Reports, eISSN is 1558-822X and pISSN is 1558-8211.
What is Citescore for Current Hematologic Malignancy Reports?
Citescore for Current Hematologic Malignancy Reports is 6.5.
What is the H Index for Current Hematologic Malignancy Reports ?
H Index for Current Hematologic Malignancy Reports is 40.
What is SNIP score for Current Hematologic Malignancy Reports?
SNIP score for Current Hematologic Malignancy Reports is 1.27.
What is the SJR for Current Hematologic Malignancy Reports?
SJR for Current Hematologic Malignancy Reports is Q2.
Who is the publisher of Current Hematologic Malignancy Reports?
CURRENT MEDICINE GROUP is the publisher of Current Hematologic Malignancy Reports.
Your document is 100% secure & confidential 
